These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 11642327)
41. [Effect of salazosulfapyridine and its metabolites on immunocompetent cells]. Ishibashi T; Hara A; Tsuboi I; Muraoka T; Shibata H; Tsunosue R; Shichijo S; Yokoyama M Ryumachi; 1989 Jun; 29(3):178-84. PubMed ID: 2573159 [TBL] [Abstract][Full Text] [Related]
42. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population. Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G; Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464 [TBL] [Abstract][Full Text] [Related]
43. Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies? Le Marchand L; Sivaraman L; Franke AA; Custer LJ; Wilkens LR; Lau AF; Cooney RV Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):449-55. PubMed ID: 8781741 [TBL] [Abstract][Full Text] [Related]
44. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis. Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096 [TBL] [Abstract][Full Text] [Related]
45. Re-investigation of the concordance of human NAT2 phenotypes and genotypes. Bolt HM; Selinski S; Dannappel D; Blaszkewicz M; Golka K Arch Toxicol; 2005 Apr; 79(4):196-200. PubMed ID: 15558239 [TBL] [Abstract][Full Text] [Related]
46. The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population. Chen B; Zhang WX; Cai WM Eur J Clin Pharmacol; 2006 May; 62(5):355-9. PubMed ID: 16570187 [TBL] [Abstract][Full Text] [Related]
47. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hein DW; Ferguson RJ; Doll MA; Rustan TD; Gray K Hum Mol Genet; 1994 May; 3(5):729-34. PubMed ID: 8081359 [TBL] [Abstract][Full Text] [Related]
48. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study. Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242 [TBL] [Abstract][Full Text] [Related]
51. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus. Irshaid YM; Abujbara MA; Ajlouni KM; El-Khateeb M; Jarrar YB Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153 [TBL] [Abstract][Full Text] [Related]
52. [Biochemical, molecular genetic and ecogenetic studies of polymorphic arylamine N-acetyltransferase (NAT2) in the brain]. Ogawa M Fukuoka Igaku Zasshi; 1999 Apr; 90(4):118-31. PubMed ID: 10361374 [TBL] [Abstract][Full Text] [Related]
53. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907 [TBL] [Abstract][Full Text] [Related]
54. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population. Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378 [TBL] [Abstract][Full Text] [Related]